Aller au contenu principal
Si vous continuez à consulter ce site web, vous acceptez nos politiques :
  • Terms and Conditions
  • Privacy & Cookies Policy
Continuer
x
  • Accueil
  • Calendrier
  • About
    About Open Classroom EUPATI Fellows Our Impact FAQ
  • Open Classroom
    Learning Catalogue Patient Expert Training Programme
  • Resources
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources
  • EUPATI website
  • Plus
Français ‎(fr_wp)‎
Čeština ‎(cs)‎ Deutsch ‎(de_wp)‎ English ‎(en_wp)‎ Español ‎(es_wp)‎ Français ‎(fr_wp)‎ Italiano ‎(it_wp)‎ Nederlands ‎(nl_wp)‎ Português - Portugal ‎(pt)‎ Ελληνικά ‎(el_wp)‎
Vous êtes connecté anonymement
Connexion

    Side Drawer

    EUPATI Open Classroom
    Course home
    Profile Calendar Accueil Calendrier About Replier Déplier
    About Open Classroom EUPATI Fellows Our Impact FAQ
    Open Classroom Replier Déplier
    Learning Catalogue Patient Expert Training Programme
    Resources Replier Déplier
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources
    EUPATI website

    Side Drawer

    Tout déplier Tout replier
    Course home
    1. Pharmacovigilance- Risk management
    2. Lesson 2: Pharmacovigilance Measures and the European EudraVigilance
    3. Additional resources (websites to check)

    Additional resources (websites to check)

    Conditions d’achèvement
    Consulter

    Additional resources

    Websites to check for more food for thought

    Additional Resources 
    • EudraVigilance
    • EudraVigilance: electronic reporting
    • EudraVigilance: how to register
    • Access to EudraVigilance data
    • EudraVigilance system overview
    • EudraVigilance change management
    • EudraVigilance training

    European Medicines Agency policy on access to EudraVigilance data for medicinal products for human use (EudraVigilance Access Policy) Available at: European Medicines Agency policy on access to EudraVigilance data for medicinal products for human use (europa.eu)

    Signal management: Signal management | European Medicines Agency (europa.eu)

    Online access to suspected side-effect reports European database of suspected adverse drug reaction reports (adrreports.eu)

    and here with access provided in all official languages of the EU: European database of suspected adverse drug reaction reports (adrreports.eu)

    Frequently asked questions about the adrreports.eu website: European database of suspected adverse drug reaction reports - Frequently asked questions (adrreports.eu)

    Previous Activity
    Next Activity

    Footer

    Vous êtes connecté anonymement (Connexion)
    Politiques
    Obtenir l’app mobile
    Fourni par Moodle

    About EUPATI

    • About Open Classroom
    • FAQ
    • Contact us

    Start learning

    • Learning Catalogue
    • Patient Expert Training Programme

    Resources

    • EUPATI Toolbox
    • Patient Involvement Roadmap
    • Accessibility Resources

    Terms of Use & Privacy

    • Terms and Conditions
    • Privacy and Cookie Policy

    The EUPATI Open Classroom was initially launched with support from the EUPATI Reload project, funded by EIT Health. EIT Health is supported by EIT, a body of the European Union. 

    For more information about EUPATI, please access our website www.eupati.eu or contact us at openclassroom@eupati.eu

    EIT Health logo and EU logo

    © 2025 EUPATI

    • https://eupati.eu/
    • https://www.linkedin.com/company/15178871/admin/dashboard/
    • https://www.youtube.com/user/PatientsAcademy
    • https://www.instagram.com/eupatients/
    • https://www.facebook.com/eupati.eu/
    Select banner image